Live Quote · NASDAQLSTAHealthcare· Biotechnology

Lisata Therapeutics, Inc.

$3.33 0.89%($-0.03)
TickerSpark Score
67/100
Solid
60
Valuation
40
Profitability
50
Growth
84
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LSTA research report →

52-Week Range47% of range
Low
$1.81
Current
$3.33
High
$5.07
Company Overviewwww.lisata.com

About the company

Lisata Therapeutics, Inc. is a clinical-stage biopharmaceutical firm focused on pioneering and bringing to market cellular therapies. These treatments are designed to either reverse disease progression or facilitate the repair of damaged bodily tissues.

CEO
David J. Mazzo
IPO
1999
Employees
26
HQ
Basking Ridge, NJ, US

Price Chart

+21.98% · this period
$5.04$3.45$1.86Jul 02Dec 31Jul 02
Valuation
Market Cap
$30.32M
P/E
-1.79
P/S
178.38
P/B
2.74
EV/EBITDA
-1.04
Div Yield
0.00%
Profitability
Gross Margin
98.82%
Op Margin
-10178.24%
Net Margin
-9618.24%
ROE
-101.90%
ROIC
-157.32%
Growth & Income
Revenue
$170.00K · -83.00%
Net Income
$-16,586,000 · 17.01%
EPS
$-1.91 · 20.42%
Op Income
$-18,209,000
FCF YoY
17.46%
Performance & Tape
52W High
$5.07
52W Low
$1.81
50D MA
$3.32
200D MA
$3.24
Beta
0.81
Avg Volume
114.10K

Get TickerSpark's AI analysis on LSTA

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jan 9, 26Mazzo David Jother81,000
Jan 9, 26Mazzo David Jother10,503
Jan 9, 26Mazzo David Jother10,515
Jan 9, 26Mazzo David Jother12,224
Jan 9, 26Mazzo David Jother7,854
Jan 9, 26Mazzo David Jother40,000
Jan 9, 26Nisco Jamesother15,000
Jan 9, 26Nisco Jamesother2,131
Jan 9, 26Nisco Jamesother2,131
Jan 9, 26Nisco Jamesother1,137
Coverage · LSTA

Our LSTA coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on LSTA yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate LSTA report →
Internal Compare

Similar companies

Peers in the same neighborhood.